Insulet Corp.

3 days ago · businesswire.com

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum on Thursday, September 24, 2026, at 12:30 p.m. (Eastern Time). The live webcast and replay of the presentation will be accessible on the Insulet Investor Relations website: investors.insulet.com/events. About.

12 days ago · seekingalpha.com

Insulet Corporation (PODD) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

12 days ago · zacks.com

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

13 days ago · zacks.com

PODD's Omnipod 5 adoption, product expansion and raised international growth outlook support its growth prospects despite competitive and cost pressures.

14 days ago · zacks.com

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

17 days ago · zacks.com

Insulet (PODD) reported earnings 30 days ago. What's next for the stock?

21 days ago · businesswire.com

NEW YORK--(BUSINESS WIRE)---- $PODD #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) and reminds investors of the August 31, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm.

21 days ago · newsfilecorp.com

New York, New York--(Newsfile Corp. - August 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Insulet Corporation (NASDAQ: PODD) between February 21, 2025 and May 26, 2026, inclusive (the "Class Period"), of the important August 31, 2026 lead plaintiff deadline. SO WHAT: If you purchased Insulet securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

21 days ago · globenewswire.com

NEW YORK, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Insulet Corporation (NASDAQ: PODD) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Insulet securities between May 21, 2025 and May 26, 2026, both dates inclusive (the “Class Period”).

21 days ago · globenewswire.com

Insulet's SEC Filings Touted Quality Assurance Inspections "At Various Steps in the Manufacturing Cycle" While Manufacturing Issues at Its Acton Facility Allegedly Led to Medical Device Corrections Affecting Millions of Pods Insulet's SEC Filings Touted Quality Assurance Inspections "At Various Steps in the Manufacturing Cycle" While Manufacturing Issues at Its Acton Facility Allegedly Led to Medical Device Corrections Affecting Millions of Pods